Although the targets of biomanufacturing have evolved from therapeutic proteins to “advanced therapies” and now to gene therapies, the issues and solutions remain the same. The production of safe, ...
AJDOVŠČINA, Slovenia--(BUSINESS WIRE)--BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of CORNERSTONE AAV Process Development ...
Recombinant adeno-associated viruses (AAVs) are ideal gene delivery vehicles that have the potential to treat a variety of diseases. Because they do not replicate without a helper virus, AAVs alone ...
Cell and gene therapies (CGTs) have begun to transform the landscape of therapeutic offerings for patients with genetic diseases and other medical conditions. For many emerging biopharmaceutical ...
PHILADELPHIA--(BUSINESS WIRE)--VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present ...
KING OF PRUSSIA, Pa., April 12, 2023 /PRNewswire/ -- The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical ...
A UK organization supporting advanced therapy innovation is working to implement continuous upstream processing for Adeno-Associated Viruses (AAV). The Cell and Gene Therapy Catapult has developed ...
Efficient production of Adeno-Associated Virus (AAV) vectors at scale for in vivo gene therapies remains a key bottleneck for broad patient access and sustainable manufacturing costs. -- Virica and ...
Novel AEX screening kit – now available for AAV6 – and an expansive suite of high-quality reagents designed to expedite plasmid production will help accelerate breakthroughs across multiple AAV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results